SCHEMBL29801687

SCHEMBL29801687

C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 14/20 0.47
▸ OPRK1 P41145 14/20 0.47
▸ ACE P12821 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31265332 0.96 ACE (0.43) OPRM1OPRK1ACE
SCHEMBL29801838 0.95 OPRM1 (0.52) OPRM1OPRK1ACE
SCHEMBL31593308 0.93 OPRM1 (0.41) OPRM1OPRK1ACE
SCHEMBL29801999 0.92 OPRM1 (0.48) OPRM1OPRK1ACE
SCHEMBL29802056 0.92 OPRK1 (0.46) OPRM1OPRK1ACE
SCHEMBL30905097 0.89 OPRM1 (0.42) OPRM1OPRK1ACE
SCHEMBL29801935 0.89 OPRK1 (0.44) OPRM1OPRK1ACE
SCHEMBL30844081 0.88 MAPK8 (0.45) OPRM1OPRK1
SCHEMBL29802258 0.87 OPRM1 (0.52) OPRM1OPRK1ACE
SCHEMBL31412169 0.87 OPRM1 (0.46) OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306534-A1 MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES Wuhan Innerse Pharmaceutical Inc. (CN) 2024-01-17 — — EP claimed
WO-2022188878-A1 MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES 武汉英纳氏药业有限公司 2022-09-15 — — WO claimed
EP-4306534-A1 MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES Wuhan Innerse Pharmaceutical Inc. (CN) 2024-01-17 — — EP disclosed
WO-2022188878-A1 MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES 武汉英纳氏药业有限公司 2022-09-15 — — WO disclosed
Send feedback